No statistically significant difference was observed on the peptides' effects on wtPC-3 between the two peptides examined (Student t test, n=4). The ERK 1/2 phosphorylation was also examined by western blot analysis in the PC-3 cells after stable transfection with the mock vector (mPC-3). We did not observe a significant difference in ERK 1/2 phoshorylation between wtPC-3 and mPC-3 cells. Figure S3. (A) ZEB-1 expression in PC-3PEc cells and silencing of ZEB-1 expression. PC-3PEc cells presented significantly elevated ZEB-1 mRNA levels compared to that produced by mPC-3 cells. A significant decrease of ZEB-1 expression was observed in PC3PEc ZEB-1KD cells compared to the PC-3PEc cells as assessed by qRT-PCR (Student t test, P < 0.001, n=3). The human mesenchymal cells (HMC) were used as positive control. (B) Wound healing assay analysis suggested that the PC-3PEc cells and mPC-3 cells when exogenously treated with PEc present significant difference in migration at 24 h when compared with the untreated mPC-3 or when the antiPEc antibody was introduced either in PC-3PEc cells or in addition to PEc in mPC-3 cells, (p<0.005 in every case, n=3). The analysis was obtained by the Tscratch programme (CSF, Laboratory, Swiss Federal Institute of Technology, Zurich, Switzerland).
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